Skip to content
Screener

Price / book at other companies

Pfizer logo
PfizerPFE
1.8×+0.2×
Amgen logo
AmgenAMGN
16.7×-3.4×
Incyte logo
IncyteINCY
3.6×+0.4×
PVL
Palvella TherapeuticsPVLA
7.7×+2.0×
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
4.1×+1.9×
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
6.2×+3.1×

Other financials

Income statement

See full
Revenue$129.9M+59.3%
Gross profit$118.9M+60.7%
Operating income$16.4M+212%
Net income$15.0M+194%
EPS (diluted)$0.11+185%

Balance sheet

See full
Cash & equivalents$34.4M-52.9%
Total debt$114.1M+3.6%
Total equity$220.6M+58.7%
Total assets$488.5M+38.6%

Cash flow

See full
Operating cash flow$12.6M
CapEx$158.0K+103%
Free cash flow$12.5M

Valuation

See full
Market cap$3.32B+81.4%
Enterprise value$3.4B+82.1%
P/S7.2×+0.2×

Profitability

See full
Gross margin91.1%+2.0pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.5×-0.3×
Current ratio2.9×-0.3×

Where this comes from

Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001787306-26-000051

FAQ

What is Arcutis Biotherapeutics, Inc.'s price / book?
Arcutis Biotherapeutics, Inc. (ARQT) reported price / book of 14.9× in Q2 2026.
How has Arcutis Biotherapeutics, Inc.'s price / book changed year-over-year?
Arcutis Biotherapeutics, Inc.'s price / book increased by 21.0% year-over-year, from 12.3× to 14.9×.
What is the long-term trend for Arcutis Biotherapeutics, Inc.'s price / book?
Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s price / book has grown at a 29.1% compound annual growth rate (CAGR), from 5.2× to 18.8×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Arcutis Biotherapeutics, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude